Document registry — page 14

• Register entry: Dr Florentin Vercingetorix

  CEI-RG-183Register entry2026-q3

  Submitted-evidence contributor, health-technology assessment. Independent evidence-synthesis consultancy

  30 Jul 2026
• Register entry: Dr Kamila Glendinning-Uche

  CEI-RG-184Register entry2026-q3

  Comment-period correspondent, peptide chemistry. University department of medicinal chemistry

  30 Jul 2026
• Register entry: Dr Benedikt Quenneville

  CEI-RG-185Register entry2026-q3

  Submitted-evidence contributor, clinical pharmacology. Academic clinical pharmacology unit

  30 Jul 2026
• Register entry: Anselm Mountstephen

  CEI-RG-186Register entry2026-q3

  Comment-period correspondent, medicines information. University department of pharmacy practice

  30 Jul 2026
• Register entry: Dr Fenella Lavrentiev

  CEI-RG-187Register entry2026-q3

  Comment-period correspondent, endocrinology. Endocrine surgery service

  30 Jul 2026
• Register entry: Dr Ulysses Ubertini

  CEI-RG-188Register entry2026-q3

  Submitted-evidence contributor, toxicology. University department of medicinal chemistry

  30 Jul 2026
• Register entry: Dr Ursina Ellsworth-Vance

  CEI-RG-189Register entry2026-q3

  External reviewer, hepatology. University department of hepatology

  30 Jul 2026
• Register entry: Dr Frideswide Nordhagen

  CEI-RG-190Register entry2026-q3

  Comment-period correspondent, pharmacy practice. University department of pharmacy practice

  30 Jul 2026
• Register entry: Dr Odalys Quintanilha

  CEI-RG-191Register entry2026-q3

  Submitted-evidence contributor, regulatory science. Health-technology assessment agency

  30 Jul 2026
• Register entry: Dr Lorcan Uttridge

  CEI-RG-192Register entry2026-q3

  Specialist adviser, clinical biochemistry. ISO/IEC 17025-accredited contract testing laboratory

  30 Jul 2026
• Register entry: Quintus Kettlewell

  CEI-RG-193Register entry2026-q3

  Comment-period correspondent, toxicology. National pharmacovigilance centre

  30 Jul 2026
• Register entry: Dr Wojciech Oyelaran-Steen

  CEI-RG-194Register entry2026-q3

  Submitted-evidence contributor, mass spectrometry. ISO/IEC 17025-accredited contract testing laboratory

  30 Jul 2026
• Register entry: Dr Radoslava Palmgren-Kofi

  CEI-RG-195Register entry2026-q3

  External reviewer, nephrology. University teaching hospital, department of endocrinology

  30 Jul 2026
• Register entry: Dr Delphine Trelawney

  CEI-RG-196Register entry2026-q3

  External reviewer, clinical pharmacology. Academic clinical pharmacology unit

  30 Jul 2026
• Register entry: Dr Katarzyna Yorkstone

  CEI-RG-197Register entry2026-q3

  External reviewer, cardiovascular outcomes. Primary-care research network

  30 Jul 2026
• Register entry: Dr Ludmila Castellanos-Reid

  CEI-RG-198Register entry2026-q3

  External reviewer, paediatric endocrinology. University teaching hospital, department of endocrinology

  30 Jul 2026
• Register entry: Dr Quentin Gwynne-Sarpong

  CEI-RG-199Register entry2026-q3

  Comment-period correspondent, public health. Primary-care research network

  30 Jul 2026
• Register entry: Dr Ivo Quintanilha

  CEI-RG-200Register entry2026-q3

  Comment-period correspondent, evidence synthesis. University department of public health

  30 Jul 2026
• Register entry: Dr Dmitri Nordhagen

  CEI-RG-201Register entry2026-q3

  Specialist adviser, endocrinology. Metabolic medicine service, tertiary centre

  30 Jul 2026
• Register entry: Dr Torvald Kettlewell

  CEI-RG-202Register entry2026-q3

  External reviewer, cardiovascular outcomes. University teaching hospital, department of endocrinology

  30 Jul 2026
• Register entry: Dr Jolanta Uttridge

  CEI-RG-203Register entry2026-q3

  Comment-period correspondent, pharmaceutics. University department of pharmacy practice

  30 Jul 2026
• Register entry: Dr Vasilisa Sandringham-Adu

  CEI-RG-204Register entry2026-q3

  External reviewer, public health. Primary-care research network

  30 Jul 2026
• Register entry: Dr Ngozi Zetterlund

  CEI-RG-205Register entry2026-q3

  Comment-period correspondent, paediatric endocrinology. University teaching hospital, department of endocrinology

  30 Jul 2026
• Register entry: Ciarán Jankowiak-Osei

  CEI-RG-206Register entry2026-q3

  Submitted-evidence contributor, microbiological quality. Hospital microbiology and endotoxin testing service

  30 Jul 2026
• Register entry: Dr Theodora Trelawney

  CEI-RG-207Register entry2026-q3

  External reviewer, clinical biochemistry. ISO/IEC 17025-accredited contract testing laboratory

  30 Jul 2026
• Register entry: Dr Perpetua Haverkamp-Diallo

  CEI-RG-208Register entry2026-q3

  Comment-period correspondent, regulatory science. Regulatory affairs, marketing-authorisation holder

  30 Jul 2026
• Register entry: Bertrand Ollerenshaw

  CEI-RG-209Register entry2026-q3

  Comment-period correspondent, regulatory science. Regulatory affairs, marketing-authorisation holder

  30 Jul 2026
• Register entry: Dr Liesbeth Nordhagen

  CEI-RG-210Register entry2026-q3

  Comment-period correspondent, regulatory science. Global regulatory policy, marketing-authorisation holder

  30 Jul 2026
• Register entry: Ngozi Brackenridge

  CEI-RG-211Register entry2026-q3

  Comment-period correspondent, regulatory science. Regulatory affairs, generic medicines sector

  30 Jul 2026
• Register entry: Dr Matthias Wintringham

  CEI-RG-212Register entry2026-q3

  Comment-period correspondent, regulatory science. Medical affairs, marketing-authorisation holder

  30 Jul 2026
• Register entry: Saoirse Petrossian

  CEI-RG-213Register entry2026-q3

  Comment-period correspondent, regulatory science. Regulatory affairs, contract development and manufacturing organisation

  30 Jul 2026
• Register entry: Dr Wolfram Quintanilha

  CEI-RG-214Register entry2026-q3

  Comment-period correspondent, regulatory science. Regulatory affairs, marketing-authorisation holder

  30 Jul 2026
• Register entry: Jacinta Ravensworth

  CEI-RG-215Register entry2026-q3

  Comment-period correspondent, regulatory science. Regulatory affairs, generic medicines sector

  30 Jul 2026
• Register entry: Dr Constança Glendinning-Uche

  CEI-RG-216Register entry2026-q3

  Comment-period correspondent, health-technology assessment. Health-technology assessment agency

  30 Jul 2026
• Register entry: Dr Evander Ashworth-Danquah

  CEI-RG-217Register entry2026-q3

  Comment-period correspondent, health-technology assessment. Health-technology assessment agency

  30 Jul 2026
• Synthesis: Exenatide in type 2 diabetes mellitus: effect on the anchor outcome

  CEI-ES-042Evidence synthesis2026-q3

  In the population defined for type 2 diabetes mellitus, what is the effect of Exenatide compared with the comparator used in its contributing trials on the anchor…

  High28 Jul 2026
• Draft standard CEI-MS-20: Photostability assessment of light-sensitive peptides

  CEI-CP-097Public comment period2026-q2

  Consultation on the draft of CEI-MS-20, which specifies the performance a determination must achieve for stability and states what the resulting figure does not…

  26 Jul 2026
• Indication assessment: Biological ageing and healthspan endpoints

  CEI-IN-30Indication assessment2026-q3

  Interventions proposed to modify rate of biological ageing, assessed by composite biomarker clocks, functional measures, or mortality.

  25 Jul 2026
• Supplier dossier: Shanghai Wibson Biotechnology Co., Ltd.

  CEI-SD-13Supplier dossier2025-q4

  Peptides, SARMs, injectable oils and raw materials.

  23 Jul 2026
• Draft scoping review: change in lean mass during pharmacologically induced weight reduction

  CEI-CP-017Public comment period2026-q2

  Consultation on the draft scoping review of change in lean mass during pharmacologically induced weight reduction. The review is scoping rather than an intervention…

  21 Jul 2026

page 14 of 41